Inventor
GAUR AMITABH
US11 patents
⚠️ This page may combine multiple inventors who share the name “GAUR AMITABH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUROCRINE BIOSCIENCES INC
7 patentsUS5948764ASep 7, 1999
Methods for treatment of multiple sclerosis utilizing peptide analogues of human myelin basic protein
NEUROCRINE BIOSCIENCES INC32 citations91
US6251396B1Jun 26, 2001
Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
NEUROCRINE BIOSCIENCES INC46 citations89
US6379670B1Apr 30, 2002
Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
NEUROCRINE BIOSCIENCES INC16 citations81
US6329499B1Dec 11, 2001
Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein
NEUROCRINE BIOSCIENCES INC10 citations72
US6740638B2May 25, 2004
Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
NEUROCRINE BIOSCIENCES INC3 citations61
US6562942B1May 13, 2003
Methods for treatment of diabetes using peptide analogues of insulin
NEUROCRINE BIOSCIENCES INC4 citations61
US6933274B2Aug 23, 2005
Methods for treatment of diabetes using a peptide analogues of insulin
NEUROCRINE BIOSCIENCES INC1 citations51
STANFORD UNIVERSITY MEDICAL CT
2 patentsUS6489299B2Dec 3, 2002
Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
STANFORD UNIVERSITY MEDICAL CT12 citations71
US6369033B1Apr 9, 2002
Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
STANFORD UNIVERSITY MEDICAL CT3 citations60